Emcure Pharmaceuticals Ltd.
EMCURE
Rang in Aktien
#4306
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Aktienkurs
$19.00
Marktkapitalisierung
$3.60B
Veränderung (1 Tag)
-2.14%
Veränderung (1 Jahr)
20.12%
Land
IN
Handel Emcure Pharmaceuticals Ltd. (EMCURE)
Kategorie
Healthcare
Dividendenrendite-Verlauf für Emcure Pharmaceuticals Ltd. (EMCURE)
Dividendenrendite (TTM) von Emcure Pharmaceuticals Ltd. (Aktienkürzel: EMCURE) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Emcure Pharmaceuticals Ltd. (EMCURE) von 2025 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
| Jahr | Dividendenrendite | ändert |
|---|---|---|
| 2025 | 0.00% | 0.00% |
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | Dividendenrendite | Land |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
